How many studies have been conducted on Dichlorphenamide?

BiohacksAI has indexed 125 PubMed studies on Dichlorphenamide, including 7 randomized controlled trials (RCTs). 22% of studies involve human subjects.

What are the main research areas for Dichlorphenamide?

The primary research domains for Dichlorphenamide are 👁️ Vision & Eye, 🫁 Respiratory, ❤️ Cardiovascular. This is based on analysis of 125 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Dichlorphenamide

A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.

125+ PubMed studies analyzed · 7 RCTs · Evidence Score: 46.1

Research Domains

Dichlorphenamide has been studied across 10 research domains including 👁️ Vision & Eye, 🫁 Respiratory, ❤️ Cardiovascular, 🧠 Focus & Attention, 🫘 Kidney. The primary research focus is 👁️ Vision & Eye with 18% of studies addressing this area.

Loading evidence profile...

This evidence profile for Dichlorphenamide is generated deterministically from 125 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.